Literature DB >> 23438161

Oxidative stress status in recently abstinent methamphetamine abusers.

Ming-Chyi Huang1, Shih-Ku Lin, Chun-Hsin Chen, Chun-Hung Pan, Chao-Hui Lee, Hsing-Cheng Liu.   

Abstract

AIM: Methamphetamine (METH) administration is associated with excessive oxidative stress. It is not known whether the systemic oxidative stress indices would alter during early abstinence in METH abusers with positive urine testing for recent METH exposure.
METHODS: Sixty-four non-treatment-seeking METH abusers enrolled from a controlled environment and 60 healthy controls participated in the study. Fasting serum malondialdehyde (MDA) levels and anti-oxidant indices, including superoxide dismutase (SOD) and catalase (CAT) activity, and glutathione (GSH) levels, were measured at baseline and 2 weeks after the first measurement. We compared the differences of these oxidative stress indices between METH abusers and controls and examined the changes of the indices 2 weeks after baseline in the METH group.
RESULTS: At baseline, the recently abstinent METH abusers had significantly higher MDA levels, lower SOD activity, and higher CAT activity and GSH levels compared to healthy controls. CAT and GSH values were positively correlated with MDA but negatively correlated with SOD. These oxidative stress indices did not significantly correlate with age, smoking amount, Alcohol Use Disorder Identification Test scores, or METH use variables. After 2 more weeks of abstinence, the indices did not alter nor normalize.
CONCLUSION: Compared to controls, we found that METH abusers have persistently higher systemic oxidative stress throughout early abstinence. The compromised SOD as well as elevated CAT activity and GSH levels may act together as a compensatory mechanism to counteract excessive oxidative stress induced by METH. Whether the oxidative stress could improve after a longer period of abstinence needs to be examined in future studies.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23438161     DOI: 10.1111/pcn.12025

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  14 in total

1.  Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.

Authors:  David M Hedges; J Daniel Obray; Jordan T Yorgason; Eun Young Jang; Vajira K Weerasekara; Joachim D Uys; Frederick P Bellinger; Scott C Steffensen
Journal:  Neuropsychopharmacology       Date:  2017-11-29       Impact factor: 7.853

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 3.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

Review 4.  Methamphetamine, neurotransmitters and neurodevelopment.

Authors:  B Čechová; R Šlamberová
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

5.  Sex differences in neurobehavioral consequences of methamphetamine exposure in adult mice.

Authors:  Delaney L Davis; Daniel B Metzger; Philip H Vann; Jessica M Wong; Kumudu H Subasinghe; Isabelle K Garlotte; Nicole R Phillips; Ritu A Shetty; Michael J Forster; Nathalie Sumien
Journal:  Psychopharmacology (Berl)       Date:  2022-03-26       Impact factor: 4.415

6.  The Effects of Non-selective Dopamine Receptor Activation by Apomorphine in the Mouse Hippocampus.

Authors:  Luis Enrique Arroyo-García; Rubén Antonio Vázquez-Roque; Alfonso Díaz; Samuel Treviño; Fidel De La Cruz; Gonzalo Flores; Antonio Rodríguez-Moreno
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

7.  Epigallocatechin Gallate Mitigates the Methamphetamine-Induced Striatal Dopamine Terminal Toxicity by Preventing Oxidative Stress in the Mouse Brain.

Authors:  Allen L Pan; Ermal Hasalliu; Manjola Hasalliu; Jesus A Angulo
Journal:  Neurotox Res       Date:  2020-02-21       Impact factor: 3.911

8.  Evaluation of the health status outcome among inpatients treated for Amphetamine Addiction.

Authors:  Raed Saud Alharbi; Ahmad Hamad Alhowail; Abdullah Ghareeb Alharbi; Ashraf Mahmoud Emara
Journal:  Saudi J Biol Sci       Date:  2021-11-23       Impact factor: 4.219

9.  Chlorogenic and caftaric acids in liver toxicity and oxidative stress induced by methamphetamine.

Authors:  Khaled M M Koriem; Rowan E Soliman
Journal:  J Toxicol       Date:  2014-07-20

10.  The protective effect of gastrodin against the synergistic effect of HIV-Tat protein and METH on the blood-brain barrier via glucose transporter 1 and glucose transporter 3.

Authors:  Juan Li; Jian Huang; Yongwang He; Wenguang Wang; Chi-Kwan Leung; Dongxian Zhang; Ruilin Zhang; Shangwen Wang; Yuanyuan Li; Liu Liu; Xiaofeng Zeng; Zhen Li
Journal:  Toxicol Res (Camb)       Date:  2021-01-22       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.